Yoshimura M, Kambara S, Okabayashi H, Takahashi H, Ijichi H
Clin Exp Hypertens A. 1987;9(7):1141-57. doi: 10.3109/10641968709160039.
To clarify role of dopamine in the development of hypertension, the effect of a dopamine synthesis inhibitor on blood pressure and urinary output of catecholamines was investigated in spontaneously hypertensive rats (SHR) fed with high sodium diet. Rats were orally given carbidopa, an inhibitor of peripheral DOPA decarboxylase, or the vehicle for 4 weeks. Carbidopa administration accelerated significantly the development of hypertension as compared to the control SHRs with the vehicle. Carbidopa administration resulted in a significant decrease of urinary excreted sodium, urinary dopamine and renal content of dopamine. Conversely, carbidopa administration resulted in a significant increase of urinary excreted norepinephrine, urinary epinephrine and renal content of norepinephrine as compared with control SHRs. These results suggest that decreased dopamine synthesis in kidneys and probably other peripheral tissue accelerates the development of hypertension, mediated by a decrease of natriuresis and an enhancement of sympatho-adrenomedullary activity. Dopamine plays an important role in its protective action against the development of hypertension enhanced by salt loading, and decreased dopaminergic mechanisms accelerated hypertension in SHR.
为阐明多巴胺在高血压发展过程中的作用,我们在喂食高钠饮食的自发性高血压大鼠(SHR)中研究了多巴胺合成抑制剂对血压和儿茶酚胺尿量的影响。大鼠口服外周多巴脱羧酶抑制剂卡比多巴或赋形剂,持续4周。与服用赋形剂的对照SHR相比,服用卡比多巴显著加速了高血压的发展。服用卡比多巴导致尿钠排泄、尿多巴胺和肾脏多巴胺含量显著降低。相反,与对照SHR相比,服用卡比多巴导致尿去甲肾上腺素、尿肾上腺素排泄及肾脏去甲肾上腺素含量显著增加。这些结果表明,肾脏及可能其他外周组织中多巴胺合成减少通过利钠减少和交感-肾上腺髓质活动增强介导,加速了高血压的发展。多巴胺在其对盐负荷增强的高血压发展的保护作用中起重要作用,并且多巴胺能机制降低加速了SHR的高血压进程。